| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.092 | 0.08 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.08 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.08 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.08 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | 0.076 | 0.08 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.08 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.09 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.09 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.1 | 0.09 |